0001752724-21-001881.txt : 20210113
0001752724-21-001881.hdr.sgml : 20210113
20210113134809
ACCESSION NUMBER: 0001752724-21-001881
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20201031
FILED AS OF DATE: 20210113
DATE AS OF CHANGE: 20210113
EFFECTIVENESS DATE: 20210113
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: SCHWAB INVESTMENTS
CENTRAL INDEX KEY: 0000869365
IRS NUMBER: 000000000
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0831
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-06200
FILM NUMBER: 21525751
BUSINESS ADDRESS:
STREET 1: 211 MAIN STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 1-415-667-7000
MAIL ADDRESS:
STREET 1: 211 MAIN STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
0000869365
S000006807
Schwab 1000 Index Fund
C000018433
Schwab 1000 Index Fund
SNXFX
N-CEN
1
primary_doc.xml
X0303
N-CEN
LIVE
0000869365
XXXXXXXX
811-06200
false
false
false
N-1A
S000006807
C000018433
SCHWAB INVESTMENTS
811-06200
0000869365
549300V41RCJNTEW5K68
211 MAIN STREET
SAN FRANCISCO
94105
US-CA
US
800-648-5300
Charles Schwab Investment Management, Inc.
211 Main Street
San Francisco
94105
800-648-5300
Investment Adviser and Fund Administrator Records
State Street Bank and Trust Company
One Lincoln Street
Boston
02111
617-786-3000
Custodian Records
Schwab Investments
211 Main Street
San Francisco
94105
800-648-5300
Trust and Fund Records
Charles Schwab & Co., Inc.
211 Main Street
San Francisco
94105
800-648-5300
Principal Underwriter Records
DST Asset Manager Solutions, Inc.
2000 Crown Colony Drive
Quincy
02169
800-407-0256
Transfer Agent Records
N
N
N-1A
8
Y
David L. Mahoney
000000000
N
Jane P. Moncreiff
000000000
N
Walter W. Bettinger II
002915574
Y
Joseph R. Martinetto
002996277
Y
Nancy F. Heller
001813276
N
John F. Cogan
000000000
N
Kiran M. Patel
000000000
N
Robert W. Burns
000000000
N
Kimberly S. Patmore
000000000
N
Stephen Timothy Kochis
002293884
N
Gerald B. Smith
000500814
N
Jonathan de St. Paer
004731700
Y
Michael Hogan
002986381
211 Main Street
San Francisco
94105
XXXXXX
N
N
N
N
N
N
N
Charles Schwab & Co., Inc.
8-16514
000005393
549300ZP8XN77GK5BS04
Y
N
Deloitte & Touche LLP
34
00000000000000000000
Y
N
N
N
N
N
N
Schwab 1000 Index Fund
S000006807
549300POUDZNU374H849
N
1
0
0
Y
N
0.00000000
-0.05000000
0.00000000
0.00000000
N
N
Y
N
N
Goldman Sachs Bank USA
KD3XUN7C6T14HNAYLU02
N
N
Cash collateral reinvestment fee
Revenue sharing split
4402680.34000000
153611.12000000
Rule 32a-4 (17 CFR 270.32a-4)
Rule 17a-7 (17 CFR 270.17a-7)
N
N
N
N
Charles Schwab Investment Management, Inc.
801-35905
000106753
EVQ6EP3QESDF386W4D54
N
DST Asset Manager Solutions, Inc.
84-00896
00000000000000000000
N
N
N
ICE Data Services, Inc.
13-3668779
Tax ID
N
Refinitiv US Holdings Inc.
549300NF240HXJO7N016
N
N
State Street Bank and Trust Company
571474TGEMMWANRLN572
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
State Street Trust Company Canada
549300L71XG2CTQ2V827
CA
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
N
DST Asset Manager Solutions, Inc.
84-00896
SEC File Number
N
N
N
Charles Schwab Investment Management, Inc.
EVQ6EP3QESDF386W4D54
Y
N
N
Charles Schwab & Co., Inc.
8-16514
000005393
549300ZP8XN77GK5BS04
0.00000000
TD Ameritrade Hong Kong Limited
N/A
000000000
00000000000000000000
HK
0.00000000
Charles Schwab, Hong Kong, Ltd.
N/A
000000000
00000000000000000000
HK
0.00000000
Charles Schwab Singapore Pte. Ltd.
N/A
000000000
00000000000000000000
SG
0.00000000
TD Ameritrade, Inc.
8-23395
000007870
CWQYQU0TV2NLMLZKNB44
0.00000000
Charles Schwab, U.K., Limited
N/A
000000000
549300PF2KTM8A12FH91
GB
0.00000000
TD Ameritrade Clearing, Inc.
8-16335
000005633
MRK678VXOI09YSSN8X19
0.00000000
TD Ameritrade Singapore Pte. Ltd.
N/A
000000000
00000000000000000000
SG
0.00000000
Charles Schwab Australia Pty Limited
N/A
000000000
00000000000000000000
AU
0.00000000
Citigroup Global Markets Inc.
8-8177
000007059
MBNUM2BPBDO7JBLYG310
15027.55000000
Wells Fargo Securities, LLC
8-65876
000126292
VYVVCKR63DVZZN70PB21
21471.88000000
Morgan Stanley & Co. LLC
8-15869
000008209
9R7GPTSO7KV3UQJZQ078
7631.39000000
J.P. Morgan Securities LLC
8-35008
000000079
ZBUT11V806EZRVTWT807
8378.32000000
Instinet, LLC
8-23669
000007897
549300MGMN3RKMU8FT57
5733.22000000
Cantor Fitzgerald & Co.
8-201
000000134
5493004J7H4GCPG6OB62
5308.56000000
Cowen and Company, LLC
8-22522
000007616
549300WR155U7DVMIW58
5048.96000000
Kepler Capital Markets, Inc.
8-67194
000139148
254900VCHS9DMDUVZN16
4498.50000000
Jane Street Execution Services, LLC
8-69254
000167280
549300HXJLXCPDWAH070
4991.98000000
Goldman Sachs & Co. LLC
8-129
000000361
FOR8UP27PHTHYVLBNG30
10417.67000000
111644.60000000
Goldman Sachs & Co. LLC
8-129
000000361
FOR8UP27PHTHYVLBNG30
15124570.02000000
Jefferies LLC
8-15074
000002347
58PU97L1C0WSRCWADL48
391222.00000000
Morgan Stanley & Co. LLC
8-15869
000008209
9R7GPTSO7KV3UQJZQ078
33347008.99000000
BofA Securities, Inc.
8-69787
000283942
549300HN4UKV1E2R3U73
18804881.38000000
J.P. Morgan Securities LLC
8-35008
000000079
ZBUT11V806EZRVTWT807
169023.00000000
67836705.39000000
N
9458513161.64000000
Uncommitted
400000000.00000000
N
Committed
850000000.00000000
N
N
N
N
true
INTERNAL CONTROL RPT
2
NCEN_2688600509435703.txt
REPORT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM
To the Board of Trustees of Schwab Investments and
Shareholders of Schwab 1000 Index Fund:
In planning and performing our audits of the financial
statements of Schwab 1000 Index Fund (the "Fund"), as of
and for the year ended October 31, 2020, in accordance with
the standards of the Public Company Accounting Oversight
Board (United States) (PCAOB), we considered the Fund's
internal control over financial reporting, including controls
over safeguarding securities, as a basis for designing our
auditing procedures for the purpose of expressing our opinion
on the financial statements and to comply with the
requirements of Form N-CEN, but not for the purpose of
expressing an opinion on the effectiveness of the Fund's
internal control over financial reporting. Accordingly, we
express no such opinion.
The management of the Fund is responsible for establishing
and maintaining effective internal control over financial
reporting. In fulfilling this responsibility, estimates and
judgments by management are required to assess the expected
benefits and related costs of controls. A fund's internal control
over financial reporting is a process designed to provide
reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for
external purposes in accordance with generally accepted
accounting principles. A fund's internal control over financial
reporting includes those policies and procedures that (1)
pertain to the maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and dispositions
of the assets of the fund; (2) provide reasonable assurance that
transactions are recorded as necessary to permit preparation of
financial statements in accordance with generally accepted
accounting principles, and that receipts and expenditures of
the fund are being made only in accordance with
authorizations of management and trustees of the trust; and (3)
provide reasonable assurance regarding prevention or timely
detection of unauthorized acquisition, use, or disposition of a
fund's assets that could have a material effect on the financial
statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions or that the degree
of compliance with the policies or procedures may deteriorate.
A deficiency in internal control over financial reporting exists
when the design or operation of a control does not allow
management or employees, in the normal course of
performing their assigned functions, to prevent or detect
misstatements on a timely basis. A material weakness is a
deficiency, or a combination of deficiencies, in internal
control over financial reporting, such that there is a reasonable
possibility that a material misstatement of the Fund's annual
or interim financial statements will not be prevented or
detected on a timely basis.
Our consideration of the Fund's internal control over financial
reporting was for the limited purpose described in the first
paragraph and would not necessarily disclose all deficiencies
in internal control that might be material weaknesses under
standards established by the PCAOB. However, we noted no
deficiencies in the Fund's internal control over financial
reporting and its operation, including controls for safeguarding
securities, that we consider to be a material weakness, as
defined above, as of October 31, 2020.
This report is intended solely for the information and use of
management and Board of Trustees of Schwab Investments
and the Securities and Exchange Commission and is not
intended to be and should not be used by anyone other than
these specified parties.
/s/ Deloitte & Touche LLP
Denver, Colorado
December 16, 2020